[Prognosis of tongue carcinoma according to the therapeutic modality--with special reference to stages I and II].
Amagasa
T
T
Shioda
S
S
Iwaki
H
H
Yokoo
E
E
Sato
T
T
Sato
K
K
Tachibana
T
T
Fujii
E
E
Hasegawa
K
K
Sasaki
T
T
D001761:Bleomycin / Q000627:therapeutic use; D001918:Brachytherapy; D002294:Carcinoma, Squamous Cell / Q000401:mortality / Q000628:therapy*; D003131:Combined Modality Therapy; D006801:Humans; D009362:Neoplasm Metastasis; D009364:Neoplasm Recurrence, Local / Q000453:epidemiology; D011379:Prognosis; D014059:Tongue / Q000601:surgery; D014062:Tongue Neoplasms / Q000401:mortality / Q000628:therapy*
D001761:Bleomycin